Dechra Pharmaceuticals Plc News - DPH | Aktien Londoner Börse

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Dechra Pharmaceuticals PLC Cancellation of listing and admission to trading

Dechra Pharmaceuticals PLC 17 January 2024 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION...

London Stock Exchange Notice Cancellation - Dechra Pharmaceuticals Plc

London Stock Exchange Notice 17 January 2024 NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON THE LONDON STOCK EXCHANGE 17/01/2024 - 08:00 At the...

Dechra Pharmaceuticals PLC Holding(s) in Company

Dechra Pharmaceuticals PLC 17 January 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB0009633180 Issuer Name...

Dechra Pharmaceuticals PLC Holding(s) in Company

Dechra Pharmaceuticals PLC 16 January 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB0009633180 Issuer Name...

Credit Industriel et Commercial Form 8.3 - Dechra Pharmaceuticals plc

Credit Industriel et Commercial 16 January 2024 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/ DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN...

MILLENNIUM PARTNERS: Form 8.3 - Dechra Pharmaceuticals plc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3...

Dechra Pharmaceuticals PLC Holding(s) in Company

Dechra Pharmaceuticals PLC 16 January 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB0009633180 Issuer Name...

NATIXIS: Form 8.3 - Dechra Pharmaceuticals plc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3...

State Street Global Advisors Form 8.3 - Dechra Pharmaceuticals plc

State Street Global Advisors 16 January 2024 Rule 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT...

Barclays PLC Form 8.3 - Dechra Pharmaceuticals plc

Barclays PLC 16 January 2024 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES...

Rathbone Brothers Form 8.3 - Dechra Pharmaceuticals Plc

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of...

Morgan Stanley & Co. Int'l plc Form 8.5 (EPT/RI)-Replacement of Dechra

Morgan Stanley & Co. Int'l plc 16 January 2024 AMMENT(2(b)) FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER...

BNP Paribas London Form 8.3 - Dechra Pharmaceuticals plc

BNP Paribas London 16 January 2024 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES...

Dechra Pharmaceuticals PLC Holding(s) in Company

Dechra Pharmaceuticals PLC 16 January 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB0009633180 Issuer Name...

Dechra Pharmaceuticals PLC Scheme of Arrangement becomes Effective

Dechra Pharmaceuticals PLC 16 January 2024 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR...

Error: 507

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Dechra Pharmaceuticals Plc (DPH)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

DPH Nachrichten

Dechra Pharmaceuticals PLC Cancellation of listing and admission to trading

London Stock Exchange Notice Cancellation - Dechra Pharmaceuticals Plc

Dechra Pharmaceuticals PLC Holding(s) in Company

Dechra Pharmaceuticals PLC Holding(s) in Company

Credit Industriel et Commercial Form 8.3 - Dechra Pharmaceuticals plc

MILLENNIUM PARTNERS: Form 8.3 - Dechra Pharmaceuticals plc

Dechra Pharmaceuticals PLC Holding(s) in Company

NATIXIS: Form 8.3 - Dechra Pharmaceuticals plc

State Street Global Advisors Form 8.3 - Dechra Pharmaceuticals plc

Barclays PLC Form 8.3 - Dechra Pharmaceuticals plc

Rathbone Brothers Form 8.3 - Dechra Pharmaceuticals Plc

Morgan Stanley & Co. Int'l plc Form 8.5 (EPT/RI)-Replacement of Dechra

BNP Paribas London Form 8.3 - Dechra Pharmaceuticals plc

Dechra Pharmaceuticals PLC Holding(s) in Company

Dechra Pharmaceuticals PLC Scheme of Arrangement becomes Effective

DPH Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Dechra Pharmaceuticals Plc (DPH) News

Dechra Pharmaceuticals Plc (DPH)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

DPH Nachrichten

Dechra Pharmaceuticals PLC Cancellation of listing and admission to trading

London Stock Exchange Notice Cancellation - Dechra Pharmaceuticals Plc

Dechra Pharmaceuticals PLC Holding(s) in Company

Dechra Pharmaceuticals PLC Holding(s) in Company

Credit Industriel et Commercial Form 8.3 - Dechra Pharmaceuticals plc

MILLENNIUM PARTNERS: Form 8.3 - Dechra Pharmaceuticals plc

Dechra Pharmaceuticals PLC Holding(s) in Company

NATIXIS: Form 8.3 - Dechra Pharmaceuticals plc

State Street Global Advisors Form 8.3 - Dechra Pharmaceuticals plc

Barclays PLC Form 8.3 - Dechra Pharmaceuticals plc

Rathbone Brothers Form 8.3 - Dechra Pharmaceuticals Plc

Morgan Stanley & Co. Int'l plc Form 8.5 (EPT/RI)-Replacement of Dechra

BNP Paribas London Form 8.3 - Dechra Pharmaceuticals plc

Dechra Pharmaceuticals PLC Holding(s) in Company

Dechra Pharmaceuticals PLC Scheme of Arrangement becomes Effective

DPH Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen